Organisation › Details

Magenta Therapeutics Inc.

Magenta Therapeutics is a biotechnology company developing therapeutics to revolutionize bone marrow transplant for patients with autoimmune diseases, blood cancers and genetic diseases. By creating a platform focused on critical areas of transplant medicine, Magenta Therapeutics is pioneering an integrated approach to extend the curative power of bone marrow transplant to more patients. Founded by internationally recognized leaders in bone marrow transplant medicine, Magenta Therapeutics was launched in 2016 by Third Rock Ventures and Atlas Venture and is headquartered in Cambridge, Massachusetts. *

 

Period Start 2016-11-16 established (approx)
Products Industry stem cell technology
  Industry 2 stem cell therapy
Person Person Gardner, Jason (Magenta Therapeutics 201611 CEO + Co-Founder)
     
Region Region Cambridge, MA
  Country United States (USA)
  Street 50 Hampshire Street
  City 02139 Cambridge, MA
  Tel +1-857-242-0170
    Address record changed: 2018-03-06
     
Basic data Employees B: 11 to 50 (2016-11-16)
     
    * Document for �About Section�: Heidelberg Pharma AG. (3/5/18). "Press Release: Heidelberg Pharma and Magenta Therapeutics Sign Exclusive MultiTarget Research Agreement for the Development of Antibody Drug Conjugates". Ladenburg & Cambridge, MA.
     
   
Record changed: 2019-07-13

Advertisement

[iito] Business Intelligence – The Elephants Are Coming 560x91px

More documents for Magenta Therapeutics Inc.


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Advertisement

Picture [iito] – Putting Information into Context 600x60px




» top